Trade Bionano Genomics, Inc. - BNGO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.1622 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.001 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 5.2389 |
| Open | 5.1989 |
| 1-Year Change | 333.24% |
| Day's Range | 5.0989 - 5.2889 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 5.2589 | 0.0600 | 1.15% | 5.1989 | 5.3189 | 5.0989 |
| Feb 20, 2025 | 5.2389 | -0.2200 | -4.03% | 5.4589 | 5.4689 | 5.1289 |
| Feb 19, 2025 | 5.4989 | -0.1000 | -1.79% | 5.5989 | 5.8089 | 5.4189 |
| Feb 18, 2025 | 5.6089 | -0.2600 | -4.43% | 5.8689 | 6.0289 | 5.6089 |
| Feb 14, 2025 | 5.7289 | 0.3100 | 5.72% | 5.4189 | 6.2489 | 5.3989 |
| Feb 13, 2025 | 5.4989 | 0.2500 | 4.76% | 5.2489 | 5.5989 | 5.1989 |
| Feb 12, 2025 | 5.3089 | 0.1200 | 2.31% | 5.1889 | 5.4289 | 4.9989 |
| Feb 11, 2025 | 5.3089 | 0.1300 | 2.51% | 5.1789 | 5.4789 | 5.0589 |
| Feb 10, 2025 | 5.2289 | -0.5100 | -8.89% | 5.7389 | 5.7389 | 5.1489 |
| Feb 7, 2025 | 5.7889 | 0.2800 | 5.08% | 5.5089 | 5.9089 | 5.4589 |
| Feb 6, 2025 | 5.6489 | 0.2700 | 5.02% | 5.3789 | 6.1589 | 5.3789 |
| Feb 5, 2025 | 5.3389 | 0.4500 | 9.20% | 4.8889 | 5.4789 | 4.8189 |
| Feb 4, 2025 | 4.9189 | -0.3000 | -5.75% | 5.2189 | 5.2189 | 4.7789 |
| Feb 3, 2025 | 5.1489 | 0.1800 | 3.62% | 4.9689 | 5.3789 | 4.7189 |
| Jan 31, 2025 | 5.0789 | -0.4000 | -7.30% | 5.4789 | 5.8189 | 5.0689 |
| Jan 30, 2025 | 5.4389 | 0.4500 | 9.02% | 4.9889 | 5.8089 | 4.9589 |
| Jan 29, 2025 | 4.9789 | -0.0100 | -0.20% | 4.9889 | 5.4489 | 4.8789 |
| Jan 28, 2025 | 5.0589 | -0.6000 | -10.60% | 5.6589 | 5.6989 | 4.9589 |
| Jan 27, 2025 | 5.7889 | -1.5011 | -20.59% | 7.2900 | 7.2900 | 5.7289 |
| Jan 24, 2025 | 0.1202 | -0.0087 | -6.75% | 0.1289 | 0.1309 | 0.1119 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Bionano Genomics, Inc. Company profile
Bionano Genomics (BNGO) is a provider of solutions for genome analysis. Additionally, the company offers diagnostic services, software and optical genome mapping solutions for basic, translational and clinical research applications.
Based in San Diego, California, the company has two businesses: Lineagen and BioDiscovery.
Lineagen provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental impairments.
Through BioDiscovery, the company also offers an industry-leading, platform-diagnostic software solution. Integrating next-generation sequencing and microarray data to analyse, visualise, interpret, and report copy number variants, single-nucleotide variants, and the absence of heterozygosity across the genome in a single consolidated view.
In October 2021, Bionano Genomics bought Biodiscovery, a software company that provides solutions for analysing, interpreting and reporting genomics data.
The acquisition is expected to accelerate the adoption of optical genome mapping (OGM), with the integration of BioDiscovery's NxClinical software solution. Saphyr System is Bionano’s featured product for OGM.
Saphyr is an ultra-sensitive genome analysis platform that can detect structural variations for mosaic samples or heterogeneous cancer samples with a false positive rate of less than 2%.
The company, founded in 2003, sells its products for research use in laboratories associated with academic and governmental research institutions. For North America and Europe, Bionano sells its products through a direct sales force. It also sells its products via third party distributors in China, Japan, South Korea, Singapore, Australia, India and South Africa.
Bionano became a public company in September 2018. Its shares are traded on the Nasdaq under the ticker symbol BNGO.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
9640 Towne Centre Drive
9640 Towne Centre Drive
SAN DIEGO
CALIFORNIA 92121
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com